Comparing objective inhaler use among COPD and Asthma populations
H. Hoch (Aurora, United States of America), L. Kaye (San Francisco, United States of America), W. Anderson (Aurora, United States of America), R. Gondalia (San Francisco, United States of America), M. Barrett (San Francisco, United States of America), M. Tuffli (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), S. Szefler (Aurora, United States of America), D. Stempel (San Francisco, United States of America)
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Hoch (Aurora, United States of America), L. Kaye (San Francisco, United States of America), W. Anderson (Aurora, United States of America), R. Gondalia (San Francisco, United States of America), M. Barrett (San Francisco, United States of America), M. Tuffli (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), S. Szefler (Aurora, United States of America), D. Stempel (San Francisco, United States of America). Comparing objective inhaler use among COPD and Asthma populations. 2272
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: